Adenoviral vector gene therapy (Institut Gustave Roussy)

N/A

Report date: 2023/10/26 16:04:09

Base Information

Drug NameAdenoviral vector gene therapy (Institut Gustave Roussy)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInstitute Gustave-Roussy
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitute Gustave-Roussy
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A